medicine-products/ssb--28la-29--28ena-29-antibody--igg-24563-1/;msg90356

Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2 Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2 Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5 New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2 New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3

[0] Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference [0] Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products [0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES [0] New silicon-germanium nanowires could lead to smaller, more powerful electronic devices

Breaking Medicine Technology:Negative Pressure Wound Devices Draw FDA Notice, Advice 2 Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2 FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2 FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3 FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 1 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 2 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 3 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 4 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 5 Pew Report Documents Challenges Faced by Philadelphia in Paying for City Workers Pensions and Health Care 50288 6 Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch Stoma Size in Gastric Bypass Patients 50285 1 Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch Stoma Size in Gastric Bypass Patients 50285 2 Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch Stoma Size in Gastric Bypass Patients 50285 3 IU researchers find vibrator use to be common linked to sexual health 50281 1 IU researchers find vibrator use to be common linked to sexual health 50281 2 IU researchers find vibrator use to be common linked to sexual health 50281 3

[0] Negative Pressure Wound Devices Draw FDA Notice, Advice [0] Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline [0] FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology